Clinical Trials Browser

OTHER × Has results × Urinary Bladder Diseases × Clear all

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Neoplasms, Neoplasms by Site, Recurrence, Urogenital Neoplasms, Urologic Diseases

NCT02901548 2022-07-29

Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder

Phase 2 Terminated

17 enrolled 9 charts

Genitourinary

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT00210249 2022-02-04

PHRC2003

Completed

364 enrolled 4 charts

GenitourinaryGynecologicLymphoid

Urinary Bladder Diseases, Digestive System Diseases, Lung Diseases, Lymphoma, Neoplasms, Ovarian Diseases, Prostatic Diseases

NCT02300610 2019-08-01

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

Phase 1 Completed

10 enrolled 14 charts

Genitourinary

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma, Carcinoma, Transitional Cell, Ureteral Diseases, Ureteral Neoplasms, Urethral Neoplasms

Clinical Trials

CISTO

Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder

PHRC2003

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer